[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100151548":3},{"organization":4,"armGroups":7,"interventions":36,"overallOfficials":42,"centralContacts":42,"locations":51,"responsibleParty":72,"collaborators":42,"id":74,"slug":75,"hasResults":76,"nctId":77,"briefTitle":78,"officialTitle":42,"acronym":42,"eligibilityCriteria":79,"healthyVolunteers":80,"sex":81,"minAge":82,"maxAge":83,"enrollmentInfo":84,"targetDuration":42,"studyType":87,"phases":88,"briefSummary":90,"conditions":91,"keywords":42,"overallStatus":93,"whyStopped":42,"lastUpdateSubmitDate":94,"lastUpdatePostDateStruct":95,"startDateStruct":97,"completionDateStruct":99,"leadSponsor":101,"locationsCount":102},{"fullName":5,"class":6},"Johnson & Johnson Vision Care, Inc.","INDUSTRY",[8,16,20,24,28,32],{"label":9,"type":10,"description":11,"interventionNames":12},"galy A Plus\u002F galy A \u002F seno A","OTHER","Pair 1: galy A Plus-subjects were randomized to receive different base curves for each eye (BC: 8.3 or 8.7).\n\nPair 2: galy A-subjects were randomized to receive different base curves for each eye (BC: 8.3 or 8.7).\n\nPair 3: seno A- subjects were randomized to receive different base curves for each eye (BC: 8.4 or 8.8).",[13,14,15],"Device: galy A Plus","Device: seno A","Device: galy A",{"label":17,"type":10,"description":18,"interventionNames":19},"galy A Plus \u002F seno A \u002F galy A","Pair 1: galy A Plus-subjects were randomized to receive different base curves for each eye (BC: 8.3 or 8.7).\n\nPair 2: seno A- subjects were randomized to receive different base curves for each eye (BC: 8.4 or 8.8).\n\nPair 3: galy A-subjects were randomized to receive different base curves for each eye (BC: 8.3 or 8.7).",[13,14,15],{"label":21,"type":10,"description":22,"interventionNames":23},"galy A \u002F galy A Plus \u002F seno A","Pair 1: galy A-subjects were randomized to receive different base curves for each eye (BC: 8.3 or 8.7).\n\nPair 2: galy A Plus-subjects were randomized to receive different base curves for each eye (BC: 8.3 or 8.7).\n\nPair 3: seno A- subjects were randomized to receive different base curves for each eye (BC: 8.4 or 8.8).",[13,14,15],{"label":25,"type":10,"description":26,"interventionNames":27},"galy A \u002F seno A \u002F galy A Plus","Pair 1: galy A-subjects were randomized to receive different base curves for each eye (BC: 8.3 or 8.7).\n\nPair 2: seno A- subjects were randomized to receive different base curves for each eye (BC: 8.4 or 8.8).\n\nPair 3: galy A Plus-subjects were randomized to receive different base curves for each eye (BC: 8.3 or 8.7).",[13,14,15],{"label":29,"type":10,"description":30,"interventionNames":31},"seno A \u002F galy A \u002F glay A Plus","Pair 1: seno A- subjects were randomized to receive different base curves for each eye (BC: 8.4 or 8.8).\n\nPair 2: galy A-subjects were randomized to receive different base curves for each eye (BC: 8.3 or 8.7).\n\nPair 3: galy A Plus-subjects were randomized to receive different base curves for each eye (BC: 8.3 or 8.7).",[13,14,15],{"label":33,"type":10,"description":34,"interventionNames":35},"seno A \u002F galy A Plus \u002F galy A","Pair 1: seno A- subjects were randomized to receive different base curves for each eye (BC: 8.4 or 8.8).\n\nPair 2: galy A Plus-subjects were randomized to receive different base curves for each eye (BC: 8.3 or 8.7).\n\nPair 3: galy A -subjects were randomized to receive different base curves for each eye (BC: 8.3 or 8.7).",[13,14,15],[37,43,47],{"type":38,"name":39,"description":40,"armGroupLabels":41,"otherNames":42},"DEVICE","galy A Plus","galyfilcon A Plus, BC: 8.3 or 8.7",[21,25,17,9,29,33],null,{"type":38,"name":44,"description":45,"armGroupLabels":46,"otherNames":42},"seno A","senofilcon A, BC:8.4 or 8.8",[21,25,17,9,29,33],{"type":38,"name":48,"description":49,"armGroupLabels":50,"otherNames":42},"galy A","galyfilcon A , BC: 8.3 or 8.7",[21,25,17,9,29,33],[52,64],{"facility":42,"status":42,"city":53,"state":54,"zip":55,"country":56,"countryCode":57,"cosmosGeoPoint":58,"geoPoint":63,"contacts":42},"Farnham","Surrey","GU9 7EN","United Kingdom","UK",{"type":59,"coordinates":60},"Point",[61,62],-0.80054,51.21444,{"lat":62,"lon":61},{"facility":42,"status":42,"city":65,"state":42,"zip":66,"country":56,"countryCode":57,"cosmosGeoPoint":67,"geoPoint":71,"contacts":42},"Birmingham","B4 7ET",{"type":59,"coordinates":68},[69,70],-1.89983,52.48142,{"lat":70,"lon":69},{"type":73,"investigatorFullName":42,"investigatorTitle":42,"investigatorAffiliation":42,"oldNameTitle":42,"oldOrganization":42},"SPONSOR","100151548","comparison-of-lens-fit-and-lens-power-of-a-new-contact-lens-to-two-marketed-contact-lenses-in-a-population-of-soft-contact-lens-wearers-100151548",true,"NCT01244529","Comparison of Lens Fit and Lens Power of a New Contact Lens to Two Marketed Contact Lenses in a Population of Soft Contact Lens Wearers","Inclusion Criteria:\n\n* Must be at least 18 years of age and no more than 55 years of age.\n* Must sign written informed consent.\n* Optimal spherical equivalent distance correction must be between -1.00 and -6.00 diopters.\n* Have spectacle astigmatism ≤ -0.75 diopter cylinder in both eyes.\n* Must have visual acuity best correctable to 20\u002F25+3 or better for each eye.\n* Must appear able and willing to adhere to the instructions set forth in this clinical protocol.\n* Have normal eyes with no evidence of abnormality or disease. For the purposes of this study a normal eye is defined as one having: No evidence of lid abnormality or infection; No conjunctival abnormality or infection; No clinical significant slit lamp findings, (i.e., oedema, staining, scarring, vascularization, infiltrates or abnormal opacities); No other active ocular disease.\n* The subject is a current spherical soft contact lens wearer (defined as a minimum of 6 hours of daily wear for a minimum of 1 month prior to the study) and willing to wear the study lenses on a daily wear basis (defined as a minimum of 6 hours of wear per day at least five days of the week) for the duration of the study.\n\nExclusion Criteria:\n\n* Any systemic illness which would contraindicate lens wear or the medical treatment of which would affect vision or successful lens wear.\n* Any previous eye surgery involving the anterior segment.\n* Pre-existing ocular disease that would preclude contact lens fitting.\n* Abnormal lacrimal secretions.\n* Keratoconus or other corneal irregularity.\n* Pregnancy, lactating or planning a pregnancy at the time of enrollment.\n* Participation in any concurrent clinical trial.\n* Subject's habitual contact lens type is toric or multifocal.\n* Require any concurrent ocular medication.",false,"ALL","18 Years","55 Years",{"count":85,"type":86},41,"ACTUAL","INTERVENTIONAL",[89],"NA","The purpose of this study is to evaluate the comparability of lens fit and lens power of a new contact lens to the lens fit and lens power of two marketed lenses.",[92],"Myopia","COMPLETED","2018-06-18",{"date":96,"type":86},"2018-06-19",{"date":98,"type":86},"2010-09-01",{"date":100,"type":86},"2010-11-01",{"name":5,"class":6},2]